Prabhudas Lilladher has reaffirmed its BUY recommendation on Cipla, driven by the company's strong financial performance and strategic growth initiatives.
Natco Pharma has achieved a significant milestone with the approval from the United States Food and Drug Administration (USFDA) for its generic version of Everolimus tablets for oral suspen
Biocon shares were trading 3.3% higher in today's session at Rs 391 at the time of publication of this story. The stock opened at Rs 384 and touched an intraday high at Rs 394.50.
Senores Pharmaceuticals Ltd's initial public offering (IPO), worth ₹582 crore, witnessed an extraordinary response from investors, achieving an astounding 93.69-times subscription on its final bidd